aTyr Pharma, Inc.
aTyr Pharma, Inc. (ATYR) Stock Overview
Explore aTyr Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
494.7M
P/E Ratio
-7.78
EPS (TTM)
$-0.80
ROE
-0.87%
ATYR Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of aTyr Pharma, Inc. (ATYR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.78, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.53.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.78 and a market capitalization of 494.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.